These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Protection of Rhesus monkeys against dengue virus challenge after tetravalent live attenuated dengue virus vaccination. Sun W; Nisalak A; Gettayacamin M; Eckels KH; Putnak JR; Vaughn DW; Innis BL; Thomas SJ; Endy TP J Infect Dis; 2006 Jun; 193(12):1658-65. PubMed ID: 16703509 [TBL] [Abstract][Full Text] [Related]
6. Viremia and the magnitude of the immune response upon infection of green monkeys with dengue virus type 2 are strain-dependent. Martín J; Hermida L; Castro J; Romero Y; Cardosa J; Guillén G Curr Microbiol; 2009 Dec; 59(6):579-83. PubMed ID: 19784699 [TBL] [Abstract][Full Text] [Related]
7. Vaccination of rhesus macaques against dengue-2 virus with a plasmid DNA vaccine encoding the viral pre-membrane and envelope genes. Putnak R; Fuller J; VanderZanden L; Innis BL; Vaughn DW Am J Trop Med Hyg; 2003 Apr; 68(4):469-76. PubMed ID: 12875299 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of interferences between dengue vaccine serotypes in a monkey model. Guy B; Barban V; Mantel N; Aguirre M; Gulia S; Pontvianne J; Jourdier TM; Ramirez L; Gregoire V; Charnay C; Burdin N; Dumas R; Lang J Am J Trop Med Hyg; 2009 Feb; 80(2):302-11. PubMed ID: 19190230 [TBL] [Abstract][Full Text] [Related]
9. Serotype-specific and cross-reactive neutralizing antibody responses in cynomolgus monkeys after infection with multiple dengue virus serotypes. Ito M; Katakai Y; Ono F; Akari H; Mukai RZ; Takasaki T; Kotaki A; Kurane I Arch Virol; 2011 Jun; 156(6):1073-7. PubMed ID: 21409446 [TBL] [Abstract][Full Text] [Related]
10. Callithrix penicillata: a feasible experimental model for dengue virus infection. Ferreira MS; de Castro PH; Silva GA; Casseb SM; Dias Júnior AG; Rodrigues SG; Azevedo Rdo S; Costa e Silva MF; Zauli DA; Araújo MS; Béla SR; Teixeira-Carvalho A; Martins-Filho OA; Vasconcelos PF Immunol Lett; 2014; 158(1-2):126-33. PubMed ID: 24361035 [TBL] [Abstract][Full Text] [Related]
11. Demonstration of marmosets (Callithrix jacchus) as a non-human primate model for secondary dengue virus infection: high levels of viraemia and serotype cross-reactive antibody responses consistent with secondary infection of humans. Moi ML; Takasaki T; Omatsu T; Nakamura S; Katakai Y; Ami Y; Suzaki Y; Saijo M; Akari H; Kurane I J Gen Virol; 2014 Mar; 95(Pt 3):591-600. PubMed ID: 24323638 [TBL] [Abstract][Full Text] [Related]
13. Could an experimental dengue virus infection fail to induce solid immunity against homologous viral challenge in non-human primates? Valdés I; Gil L; Lazo L; Marcos E; Martín J; Suzarte E; Castro J; Romero Y; Guillén G; Hermida L Arch Virol; 2016 Feb; 161(2):465-70. PubMed ID: 26590068 [TBL] [Abstract][Full Text] [Related]
14. Antiviral activity of chloroquine against dengue virus type 2 replication in Aotus monkeys. Farias KJ; Machado PR; Muniz JA; Imbeloni AA; da Fonseca BA Viral Immunol; 2015 Apr; 28(3):161-9. PubMed ID: 25664975 [TBL] [Abstract][Full Text] [Related]
15. Mouse models for dengue vaccines and antivirals. Plummer EM; Shresta S J Immunol Methods; 2014 Aug; 410():34-8. PubMed ID: 24440090 [TBL] [Abstract][Full Text] [Related]
16. Viremia and immunogenicity in nonhuman primates of a tetravalent yellow fever-dengue chimeric vaccine: genetic reconstructions, dose adjustment, and antibody responses against wild-type dengue virus isolates. Guirakhoo F; Pugachev K; Arroyo J; Miller C; Zhang ZX; Weltzin R; Georgakopoulos K; Catalan J; Ocran S; Draper K; Monath TP Virology; 2002 Jun; 298(1):146-59. PubMed ID: 12093182 [TBL] [Abstract][Full Text] [Related]
17. Efficacy of a live attenuated tetravalent candidate dengue vaccine in naïve and previously infected cynomolgus macaques. Koraka P; Benton S; van Amerongen G; Stittelaar KJ; Osterhaus AD Vaccine; 2007 Jul; 25(29):5409-16. PubMed ID: 17560694 [TBL] [Abstract][Full Text] [Related]
18. Pseudo-infectious reporter virus particles for measuring antibody-mediated neutralization and enhancement of dengue virus infection. Mukherjee S; Pierson TC; Dowd KA Methods Mol Biol; 2014; 1138():75-97. PubMed ID: 24696332 [TBL] [Abstract][Full Text] [Related]
19. Characterization of antibody responses to combinations of a dengue virus type 2 DNA vaccine and two dengue virus type 2 protein vaccines in rhesus macaques. Simmons M; Porter KR; Hayes CG; Vaughn DW; Putnak R J Virol; 2006 Oct; 80(19):9577-85. PubMed ID: 16973561 [TBL] [Abstract][Full Text] [Related]
20. Evaluation and analysis of dengue virus enhancing and neutralizing activities using simple high-throughput assays. Li XQ; Chen J; Huang YF; Ding XX; Liu LD; Qiu LW; Pan YX; Deng YQ; Hu DM; Di B; Qin CF; Che XY Appl Microbiol Biotechnol; 2013 Jul; 97(14):6503-11. PubMed ID: 23760532 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]